Therefore, these findings demonstrate that both CD8+ and CD4+ T cells are activated during acute primary EBV infection, with CD8+ T cells preferentially targeting early lytic antigens, while CD4+ T cells show higher responses to latent antigens. The gene discussed is CD4; the disease is Epstein-Barr virus infection.